Orca Biosystems, Inc.
Quick facts
Phase 3 pipeline
- Orca-T · Oncology
Orca-T is a monoclonal antibody that targets the PD-1 receptor.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: